1. Epigenetic aberrations in cervical cancer
   Madhumitha Kedhari Sundaram et al, 2021, Epigenetics and Reproductive Health CrossRef
2. Robust expression of EZH2 in endocervical neoplastic lesions
   Evelin Makk et al, 2019, Virchows Archiv CrossRef
3. Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
   Aditi Priya et al, 2023, Cureus CrossRef
4. Polycomb Repressor Complex 2 in Genomic Instability and Cancer
   Zoe Veneti et al, 2017, International Journal of Molecular Sciences CrossRef
5. Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia
   Phetmany Sihavong et al, 2021, Head and Neck Pathology CrossRef
6. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
   Anthos Christofides et al, 2016, Oncotarget CrossRef
7. Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy
   Yang Sun et al, 2016, Cancer Biotherapy and Radiopharmaceuticals CrossRef
8. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma
   Qian Chen et al, 2016, Oncotarget CrossRef
9. Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis
   Mei Chen et al, 2017, PLOS ONE CrossRef
10. Association of long non-coding RNA HOTAIR and MALAT1 variants with cervical cancer risk in Han Chinese women
    Meiqun Jia et al, 2019, The Journal of Biomedical Research CrossRef
11. Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas
    Evelin Makk et al, 2023, Pathology and Oncology Research CrossRef